Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QF7Z
|
|||
| Former ID |
DIB014206
|
|||
| Drug Name |
HER2/neu peptide vaccine
|
|||
| Synonyms |
HER2/neu peptide vaccine (intradermal, breast cancer)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
| Company |
Fred Hutchinson Cancer Research Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01729884) Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer. U.S. National Institutes of Health. | |||
| REF 2 | N-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells. Anticancer Res. 2009 Jul;29(7):2427-35. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.